Recent Updates
Recently added Catalysts
MASS Positive Sentiment

908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Key Takeaway: 908 Devices Inc. has appointed Kola Otitoju as its new Chief Business & Strategy Officer. This newly created role will focus on overseeing product and corporate strategy, business development, and partnership initiatives. The appointment reflects the company's aim to enhance its market presence in public health, safety, and defense-tech sectors.
Price reaction · baseline $7.3 (2026-04-20 close) · hit after-hours · clean, no other MASS news in the window
day 0 close
-0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Appointment of Kola Otitoju as Chief Business & Strategy Officer.
  • Focus on expanding market presence in public health and safety.
  • Creation of a new executive position indicates company growth.

Full Press Release Details

BURLINGTON, Mass.–(BUSINESS WIRE)–908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced that on June 1, 2026, the Compensation Committee of its Board of Directors granted options to four new non-executive employees to purchase an aggregate of 179,912 shares of 908 Devices’ common stock. The options were granted as a material inducement to employment with 908 Devices Inc. in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the 908 Devices Inc. 2026 Inducement Plan (the “Plan”).
The inducement stock option has an exercise price of $8.63 per share, which is equal to the closing price of 908 Devices’ common stock on the grant date of June 1, 2026. The inducement stock option vests over four years with 25% of the shares vesting on the first anniversary of the grant date, and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service through each applicable vesting date. The foregoing inducement awards are subject to the terms and conditions of the Plan, and the terms and conditions of the applicable award agreements covering the grant.
About 908 Devices908 Devices is revolutionizing chemical analysis with its simple handheld devices, addressing life-altering applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers in vital health, safety and defense tech applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure, and global security threats. The Company designs and manufactures innovative products that bring together the power of complementary analytical technologies, software automation, and machine learning. For more information, visit908devices.com.

IR & Media ContactBarbara RussoIR@908devices.com

Source: 908 Devices Inc.
The post908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)appeared first on908 Devices.

Frequently Asked Questions

Who is Kola Otitoju?

Kola Otitoju is the newly appointed Chief Business & Strategy Officer at 908 Devices.

What is Kola Otitoju's role at 908 Devices?

He will oversee product and corporate strategy, business development, and partnerships.

Why was the position created?

The position was created to enhance 908 Devices' market presence in various sectors.

What sectors will 908 Devices focus on?

The company will focus on public health, safety, and defense-tech applications.

Last updated: Apr 21, 2026